J Cancer 2016; 7(14):2157-2164. doi:10.7150/jca.16476 This issue Cite

Research Paper

The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis

Lin Xu1,2*, Ji-Jin Yao1,3*, Guan-Qun Zhou1, Wang-Jian Zhang4, Guo-Long Liu2, Li-Zhi Liu5, Jun Ma1, Ying Sun1✉

1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China;
2. Department of Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, 1 Panfu Road, Guangzhou 510180, Guangdong Province, People's Republic of China;
3. Department of Radiation Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519001, Guangdong Province, China;
4. Department of Medical Statistics and Epidemiology & Health Information Research Center & Guangdong Key Laboratory of Medicine, School of Public Health, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China;
5. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
*These authors contributed equally to this paper.

Citation:
Xu L, Yao JJ, Zhou GQ, Zhang WJ, Liu GL, Liu LZ, Ma J, Sun Y. The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. J Cancer 2016; 7(14):2157-2164. doi:10.7150/jca.16476. https://www.jcancer.org/v07p2157.htm
Other styles

File import instruction

Abstract

Background: The development of intensity-modulated radiotherapy (IMRT) has revolutionized the management of nasopharyngeal carcinoma (NPC). The purpose of this study was to investigate the impact of clinical stage on radiation doses to organs at risk (OARs) in NPC.

Material and Methods: One hundred and forty-eight patients with newly diagnosed and untreated NPC were prospectively enrolled. Based on the anatomic definition and pathogenesis of radiation induced injury, a total of 28 OARs surrounding the nasopharynx were contoured on axial computed tomography (CT) planning images in each patient. Dose-volume histograms, as well as the mean and maximal doses for each structure, were calculated.

Results: Radiation doses to 15 OARs (including the brain stem, temporal lobe and eye) were positively correlated with T stage, the radiation doses to 13 OARs (including the brachial plexus, parotid and thyroid) increased significantly with N stage, and the radiation doses to the spinal cord and mandible had no association with T or N stage. Based on the characteristic of excess rates, 9 OARs (e.g. spinal cord, eye, trachea, and et al.) met tolerance doses easily in all stages, 9 OARs (e.g. brain stem, temporal lobe, brachial plexus, and et al.) easily in early stages but with difficulty in advanced stages, and 10 OARs (e.g. cochlea, parotid, thyroid, and et al.) with difficulty in all stages.

Conclusions: The radiation doses to most of OARs are associated with T or N stage, and there are three kinds of patterns for them: 1) meet tolerance doses easily in all stages; 2) meet tolerance doses easily in early stages but with difficulty in advanced stages; and 3) meet tolerance doses with difficulty in all stages.

Keywords: Nasopharyngeal carcinoma, Organs at risk, Radiation doses, Excess rate, Clinical stage.


Citation styles

APA
Xu, L., Yao, J.J., Zhou, G.Q., Zhang, W.J., Liu, G.L., Liu, L.Z., Ma, J., Sun, Y. (2016). The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. Journal of Cancer, 7(14), 2157-2164. https://doi.org/10.7150/jca.16476.

ACS
Xu, L.; Yao, J.J.; Zhou, G.Q.; Zhang, W.J.; Liu, G.L.; Liu, L.Z.; Ma, J.; Sun, Y. The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. J. Cancer 2016, 7 (14), 2157-2164. DOI: 10.7150/jca.16476.

NLM
Xu L, Yao JJ, Zhou GQ, Zhang WJ, Liu GL, Liu LZ, Ma J, Sun Y. The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. J Cancer 2016; 7(14):2157-2164. doi:10.7150/jca.16476. https://www.jcancer.org/v07p2157.htm

CSE
Xu L, Yao JJ, Zhou GQ, Zhang WJ, Liu GL, Liu LZ, Ma J, Sun Y. 2016. The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. J Cancer. 7(14):2157-2164.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image